Mupiderm (Mupirocin Calcium)

Mupirocin calcium, the active ingredient in Mupiderm, is a mupirocin (monoxycarbolic acid) antibiotic presented as a topical preparation for skin use. It treats superficial bacterial skin infections such as impetigo, folliculitis and secondary infections that arise in damaged skin, and is indicated for use in both adults and children.

GNH USA supplies Mupiderm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with the product sourced from the European Union market.

Mupiderm (mupirocin calcium) is a topical antibacterial indicated for bacterial skin conditions.

Impetigo: reduces bacterial load and promotes healing of superficial lesions. Folliculitis: eliminates causative Staphylococcus bacteria and improves inflammatory lesions. Secondary bacterial skin infections: treats infection arising in damaged skin, limiting spread and facilitating recovery.

Mupiderm is generally well tolerated when applied to intact skin, but local reactions may occur.

Common Side Effects: - Itching at the application site - Burning sensation - Redness or erythema - Pain or tenderness - Dryness of the skin - Mild rash

Serious or Rare Side Effects: - Allergic contact dermatitis - Severe skin irritation or ulceration - Anaphylactic reaction (rare) - Worsening cellulitis - Stevens‑Johnson syndrome (very rare)

Before using Mupiderm, consider the following safety measures.

Pregnancy: safety not established; use only if clearly needed. Breastfeeding: unknown safety; weigh potential risks and benefits. Age: approved for use in children for indicated conditions. Allergy: avoid if known hypersensitivity to mupirocin or similar antibiotics. Application: apply a thin layer to affected area, avoid eyes, mucous membranes and broken skin. Store at room temperature: keep in original container, protect from moisture and light.

Mupiderm has limited systemic absorption, yet certain co‑applications may affect its safety or efficacy.

Major Interactions (Avoid): - Concurrent use of systemic mupirocin or other oral antibiotics with overlapping spectrum may reduce effectiveness. - Combining with topical corticosteroids on large areas may increase systemic absorption and risk of side effects.

Moderate Interactions (Monitor Closely): - Use with antiseptic agents such as chlorhexidine may increase local irritation. - Co‑application with other topical antibiotics may heighten risk of dermatitis. - Silver‑containing dressings may alter drug release from the skin.